Marc Belsky - 08 Jan 2023 Form 4 Insider Report for Kezar Life Sciences, Inc. (KZR)

Role
Chief Financial Officer
Signature
/s/ Marc Belsky
Issuer symbol
KZR
Transactions as of
08 Jan 2023
Transactions value $
$0
Form type
4
Filing time
10 Jan 2023, 15:56:25 UTC
Previous filing
07 Jan 2022
Next filing
26 Jul 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KZR Employee Stock Option (right to buy) Award $0 +195K $0.00 195K 08 Jan 2023 Common Stock 195K $6.84 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One forty-eighth (1/48th) of the shares shall vest on a monthly basis commencing on January 8, 2023, subject to the Reporting Person continuing to provide service through each such date.